{"abstract":null,"action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2015/05/07/2015-11013.html","cfr_references":[],"citation":"80 FR 26280","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":null,"disposition_notes":null,"docket_ids":["Docket No. FDA-2015-N-0001"],"dockets":[],"document_number":"2015-11013","effective_on":null,"end_page":26281,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2015/05/07/2015-11013.xml","html_url":"https://www.federalregister.gov/documents/2015/05/07/2015-11013/joint-meeting-of-the-bone-reproductive-and-urologic-drugs-advisory-committee-and-the-drug-safety-and","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2015-11013?publication_date=2015-05-07","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2015-05-07/2015-11013/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":710,"last_updated":"2026-06-24 00:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2015-05-07/pdf/2015-11013.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2015-11013.pdf?1430916389","publication_date":"2015-05-07","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2015/05/07/2015-11013.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Attachment 3 Neurovascular Quality Initiative List of Devices re: Comment from M2S, Inc.","document_id":"FDA-2015-N-0001-0116"},{"title":"Attachment 2 Neurovascular Quality initiative 2015 Procedure Inclusion/Exclusion Criteria re: Comment from M2S, Inc.","document_id":"FDA-2015-N-0001-0115"},{"title":"Transcript of the March 30-31, 2015 Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT) III Workshop on Inflammatory Bowel Disease, Day 2","document_id":"FDA-2015-N-0001-0051"},{"title":"Transcript of the March 30-31, 2015 Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT) III Workshop on Inflammatory Bowel Disease, Day 1","document_id":"FDA-2015-N-0001-0050"}],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2015-N-0001","supporting_documents_count":4,"docket_id":"FDA-2015-N-0001","regulation_id_number":null,"title":"Advisory Committee, Workshops, and Conferences Notices Various Meeting Notices (eg., Task Force Meeting, etc)","checked_regulationsdotgov_at":"2015-05-27T06:00:18Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":26280,"subtype":null,"title":"Joint Meeting of the Bone, Reproductive, and Urologic Drugs Advisory Committee, and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting","toc_doc":"Bone, Reproductive, and Urologic Drugs Advisory Committee, and the Drug Safety and Risk Management Advisory Committee","toc_subject":"Meetings:","topics":[],"type":"Notice","volume":80}